| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.aurolabs.com | |
| Market Cap | 44.25 Cr. | |
| Enterprise Value(EV) | 47.71 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 2.18 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 32.51 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 33.61 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 51.26 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 1.39 | Calculated using Price: 71.00 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 0.62 Cr. | 6,232,500 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| Auro Laboratories incorporated in 1989 is engaged in business of manufacturing active pharmaceutical ingredients (API's), intermediates and generic formulations. The company is promoted by Shri Sharat Deorah and Shri Satish Deorah. | ||
| 1 Day |
|
-0.42% |
| 1 Week |
|
-3.79% |
| 1 Month |
|
-6.70% |
| 3 Month |
|
-7.73% |
| 6 Month |
|
-17.63% |
| 1 Year |
|
-38.95% |
| 2 Year |
|
-24.99% |
| 5 Year |
|
-13.41% |
| 10 Year |
|
+610.0% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | 8.76 | 11.01 | 10.83 | 9.06 | 31.53 | 28.95 | 20.84 | 28.67 | 9.47 | |
| Return on Capital Employed (%) | 9.40 | 10.76 | 11.21 | 20.24 | 28.65 | 29.12 | 24.80 | 38.88 | 12.20 | |
| Return on Assets (%) | 2.04 | 2.89 | 3.24 | 3.11 | 12.34 | 13.78 | 12.32 | 19.34 | 5.87 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 7 | 8 | 9 | 9 | 13 | 17 | 22 | 29 | 32 | 32 | |
| Non Curr. Liab. | 7 | 8 | 7 | 11 | 8 | 6 | 5 | 4 | 3 | 5 | |
| Curr. Liab. | 13 | 14 | 10 | 6 | 10 | 10 | 6 | 9 | 20 | 16 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 27 | 29 | 26 | 27 | 30 | 33 | 32 | 42 | 55 | 53 | |
| Non Curr. Assets | 11 | 11 | 13 | 13 | 15 | 15 | 14 | 14 | 18 | 18 | |
| Curr. Assets | 16 | 18 | 12 | 14 | 16 | 19 | 18 | 28 | 37 | 34 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 27 | 29 | 26 | 27 | 30 | 33 | 32 | 42 | 55 | 53 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 34 | 33 | 28 | 35 | 41 | 47 | 44 | 54 | 51 | 54 | |
| Other Income | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |
| Total Income | 34 | 33 | 28 | 36 | 41 | 48 | 45 | 55 | 52 | 54 | |
| Total Expenditure | -31 | -30 | -25 | -31 | -34 | -40 | -38 | -43 | -46 | -50 | |
| PBIDT | 3 | 3 | 3 | 5 | 7 | 8 | 7 | 12 | 6 | 4 | |
| Interest | -2 | -2 | -2 | -1 | -1 | -1 | -1 | 0 | -1 | -1 | |
| Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
| Taxation | -2 | -1 | -2 | -2 | -3 | -1 | 0 | ||||
| Exceptional Items | |||||||||||
| PAT | 1 | 1 | 1 | 1 | 4 | 4 | 4 | 7 | 3 | 1 | |
| Adjusted EPS | 1 | 1 | 1 | 1 | 6 | 7 | 7 | 12 | 5 | 2 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 1 | 4 | -1 | 8 | 6 | 5 | 7 | 9 | 13 | -7 | |
| Cash Fr. Inv. | -1 | -1 | -1 | -2 | -2 | -2 | -3 | -2 | -4 | -5 | |
| Cash Fr. Finan. | -1 | -3 | 1 | -5 | -4 | -2 | -2 | -6 | 0 | 10 | |
| Net Change | 0 | 1 | -1 | 0 | 0 | 1 | 2 | 2 | 9 | -2 | |
| Cash & Cash Eqvt | 0 | 1 | 0 | 1 | 1 | 2 | 4 | 6 | 15 | 12 |
|
Mon, 16 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 The details of securities dematerialized during the quarter ended December 31 2022 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 have been furnished to all the stock exchanges where the shares ofthe Company are listed. |
|
Thu, 29 Dec 2022
Closure of Trading Window Pursuant to Clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulations 2015 as amended read with BSE Circular Ref No. LIST/COMP/01/2019-20 dated April 2 2019 and Companys Code of Conduct to regulate monitor and report trading in Companys Securities by Insiders we wish to inform you that the Trading Window for dealing in the securities of theCompany will remain closed for all Designated Persons (as defined in the Code) w.e.f. January 01 2023 for the purpose of consideration of unaudited Financial Results for the Quarterended December 31 2022.The Trading Window shall open 48 hours after the unaudited Financial Results for the Quarter ended December 31 2022 become generally available.The date of Board meeting of the Company for consideration and declaration of the said results will be intimated in due course. |
|
Fri, 23 Dec 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuance to Regulation 39(3) of the SEBI Regulations we wish to inform you that the belowmentioned share certificates have been reported to be lost/ misplaced. Further the Company hasreceived request from the holder of the Shares to issue Duplicate Share Certificates in lieu of theoriginal Share Certificates reported lost/ misplaced |
| Wed, 25 Jan 2023 |
High Delivery Percentage
|
Close Crossing Last Week Low
|
Closing Below Previous Low
|
Close Within 52 Week Low Zone
|
Close Below Last Week Low
|
Equities
M.F.
Sectors